These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8446678

  • 1. Effects of oxiracetam, physostigmine, and their combination on active and passive avoidance learning in mice.
    Sansone M, Castellano C, Palazzesi S, Battaglia M, Ammassari-Teule M.
    Pharmacol Biochem Behav; 1993 Feb; 44(2):451-5. PubMed ID: 8446678
    [Abstract] [Full Text] [Related]

  • 2. Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice.
    Sansone M, Castellano C, Battaglia M, Ammassari-Teule M.
    Pharmacol Biochem Behav; 1990 Jun; 36(2):389-92. PubMed ID: 2356212
    [Abstract] [Full Text] [Related]

  • 3. Effects of oxiracetam-nicotine combinations on active and passive avoidance learning in mice.
    Sansone M, Castellano C, Battaglia M, Ammassari-Teule M.
    Pharmacol Biochem Behav; 1991 May; 39(1):197-200. PubMed ID: 1924503
    [Abstract] [Full Text] [Related]

  • 4. Avoidance facilitation by nootropics.
    Sansone M, Oliverio A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1989 May; 13 Suppl():S89-97. PubMed ID: 2616794
    [Abstract] [Full Text] [Related]

  • 5. Interaction between nootropic drugs and methamphetamine on avoidance acquisition but not on locomotor activity in mice.
    Sansone M, Ammassari-Teule M, Oliverio A.
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):229-35. PubMed ID: 4096612
    [Abstract] [Full Text] [Related]

  • 6. Oxiracetam prevents haloperidol-induced passive avoidance impairment in mice.
    Castellano C, Battaglia M, Sansone M.
    Pharmacol Biochem Behav; 1992 Aug; 42(4):797-801. PubMed ID: 1513861
    [Abstract] [Full Text] [Related]

  • 7. Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice.
    Sansone M, Libri V, Pavone F, Ammassari-Teule M.
    Arch Int Pharmacodyn Ther; 1988 Aug; 291():208-16. PubMed ID: 3365063
    [Abstract] [Full Text] [Related]

  • 8. Enhancement by oxiracetam of passive avoidance improvement induced by the presynaptic muscarinic antagonist secoverine in mice.
    Ammassari-Teule M, Castellano C, Sansone M.
    Behav Brain Res; 1992 Mar 15; 47(1):93-5. PubMed ID: 1571105
    [Abstract] [Full Text] [Related]

  • 9. Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice.
    Sansone M, Battaglia M, Vetulani J.
    Pol J Pharmacol; 1995 Mar 15; 47(1):69-73. PubMed ID: 7550552
    [Abstract] [Full Text] [Related]

  • 10. [A comparative study of the nootropic properties of piracetam and oxiracetam].
    Krylova IN, Antonova LV, Kamenskiĭ AA, Iasnetsov VV.
    Farmakol Toksikol; 1991 Mar 15; 54(1):14-6. PubMed ID: 1860490
    [Abstract] [Full Text] [Related]

  • 11. Avoidance facilitation in adult mice by prenatal administration of the nootropic drug oxiracetam.
    Ammassari-Teule M, D'Amato FR, Sansone M, Oliverio A.
    Pharmacol Res Commun; 1986 Dec 15; 18(12):1169-76. PubMed ID: 3562507
    [Abstract] [Full Text] [Related]

  • 12. Effects of oxiracetam on learning and memory in animals: comparison with piracetam.
    Mondadori C, Classen W, Borkowski J, Ducret T, Buerki H, Schadé A.
    Clin Neuropharmacol; 1986 Dec 15; 9 Suppl 3():S27-38. PubMed ID: 3594453
    [Abstract] [Full Text] [Related]

  • 13. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M, Pozzi O, Biagetti R, Banfi S, Dorigotti L.
    Psychopharmacology (Berl); 1992 Dec 15; 106(2):175-8. PubMed ID: 1549645
    [Abstract] [Full Text] [Related]

  • 14. Enhancement by secoverine and physostigmine of retention of passive avoidance response in mice.
    Gower AJ.
    Psychopharmacology (Berl); 1987 Dec 15; 91(3):326-9. PubMed ID: 3104954
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Participation of dihydropyridine-sensitive calcium channels in psychotropic effects of nootropic drugs].
    Bobkov IuG, Polev PV, Machula AI, Val'dman EA, Soldatov NM, Dudkin SM.
    Biull Eksp Biol Med; 1990 Oct 15; 110(10):386-9. PubMed ID: 2177669
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and nootropic activity of 2-oxo-1-pyrrolidinesulfonic acid derivatives.
    Cerri A, Farina C, Pinza M, Banfi S.
    Farmaco; 1991 Oct 15; 46(7-8):959-66. PubMed ID: 1793478
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.